News Room

  • August 15, 2016
    Altasciences CEO Named PharmaVOICE 100 Most Inspiring People in the Life-Sciences Industry
    LAVAL, QC, Canada (August 15, 2015) — Altasciences, one of the largest early phase clinical CROs in North America, is pleased to announce that Chris Perkin, CEO, has been named one of the 100 Most Inspiring People in the Life-Sciences Industry by PharmaVOICE magazine for the second time.
  • June 1, 2016
    Second iCardiac Certified Site for Altasciences Clinical Research
    LAVAL, QC, Canada (June 1, 2016) — Altasciences Clinical Research announced today that its clinical facility, Algorithme Pharma, in Montreal, Canada, has received its iCardiac Certification. In January 2015, Altasciences’ Overland Park site, Vince & Associates Clinical Research, became the first clinical research provider in the world to be iCardiac certified. High-precision technology is opening a new era where QT analysis can be conducted in earlier, first-in-human studies – before sponsors commit to further development work.
  • May 19, 2016
    Vince & Associates Clinical Research Announces Research Campus Expansion
  • March 23, 2016
    Altasciences Clinical Research Companies Recognized for Leadership
    LAVAL, QC, Canada (March 23, 2016) — Altasciences Clinical Research announced today that its companies, Algorithme Pharma and Vince & Associates Clinical Research, have been identified as industry leaders by biopharmaceutical companies worldwide.
  • February 24, 2016
    Vince & Associates Clinical Research Opens Indoor Smoking Facility for Clinical Trials
    OVERLAND PARK, KS (February 24, 2016) – Vince & Associates Clinical Research, an Altasciences company, announced today the opening of a controlled ventilation indoor smoking facility offering a human laboratory model of smoking behavior at their clinical research unit in Overland Park, KS.

Pages